glp 1 receptor agonists for type 2 diabetes GLP-1 in the treatment of – state-of-the-art Glucagon-like peptide 1(GLP-1) receptor agonists
Description
Some plans exclude weight loss medications altogether
Other GLP-1 RA have also been approved but either no longer exist on the market or are not as frequently used
69705-5/asset/079012c9-a24f-4391-ba39-2f5d03668f6f/main.assets/gr1_lrg.jpg)
Amycretin is Novo Nordisks GLP-1 and amylin receptor agonist, being developed in both injectable and oral forms
If youre looking for a less costly alternative to a medication like semaglutide, you can explore other GLP-1 agonist options
This is because no specific funding had been allocated for this purpose
